Anika Therapeutics, Inc. (ANIK)
NASDAQ: ANIK · Real-Time Price · USD
9.60
+0.11 (1.16%)
At close: Dec 5, 2025, 4:00 PM EST
9.60
0.00 (0.00%)
After-hours: Dec 5, 2025, 5:01 PM EST
Anika Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 138 | 241 | 332 | 432 | 517 | 643 | |
| Market Cap Growth | -44.53% | -27.34% | -23.28% | -16.40% | -19.60% | -13.05% | |
| Enterprise Value | 105 | 206 | 290 | 376 | 447 | 567 | |
| Last Close Price | 9.60 | 16.46 | 22.66 | 29.60 | 35.83 | 45.26 | |
| PE Ratio | - | - | - | - | 125.13 | - | |
| Forward PE | 53.33 | 39.19 | - | - | - | 62.00 | |
| PS Ratio | 1.23 | 2.01 | 2.75 | 3.80 | 3.50 | 4.93 | |
| PB Ratio | 0.94 | 1.57 | 1.56 | 1.51 | 1.80 | 2.36 | |
| P/TBV Ratio | 1.01 | 1.67 | 1.64 | 2.12 | 2.63 | 3.72 | |
| P/FCF Ratio | 213.65 | - | - | - | 158.96 | 56.25 | |
| P/OCF Ratio | 17.02 | 44.62 | - | 98.08 | 61.60 | 49.24 | |
| PEG Ratio | - | 4.60 | - | - | 161.40 | 3.10 | |
| EV/Sales Ratio | 0.93 | 1.72 | 2.40 | 3.30 | 3.03 | 4.34 | |
| EV/EBITDA Ratio | - | 56.88 | 18.37 | 20.70 | 194.39 | 151.74 | |
| EV/EBIT Ratio | - | - | 182.42 | 102.39 | - | - | |
| EV/FCF Ratio | 161.98 | - | - | - | 137.51 | 49.55 | |
| Debt / Equity Ratio | 0.17 | 0.17 | 0.13 | 0.11 | 0.07 | 0.08 | |
| Debt / EBITDA Ratio | 108.08 | 3.48 | 1.42 | 1.44 | 4.12 | 3.52 | |
| Debt / FCF Ratio | 37.82 | - | - | - | 6.44 | 1.96 | |
| Asset Turnover | 0.54 | 0.51 | 0.39 | 0.33 | 0.41 | 0.38 | |
| Inventory Turnover | 1.80 | 1.80 | 1.17 | 1.07 | 1.42 | 1.80 | |
| Quick Ratio | 4.20 | 3.40 | 3.06 | 4.33 | 4.17 | 3.32 | |
| Current Ratio | 5.32 | 4.88 | 5.26 | 6.07 | 5.66 | 4.81 | |
| Return on Equity (ROE) | -8.73% | -4.82% | -1.38% | 0.77% | 1.48% | -8.55% | |
| Return on Assets (ROA) | -3.50% | -1.19% | 0.32% | 0.66% | -2.11% | -1.75% | |
| Return on Capital (ROIC) | -3.89% | -1.34% | 0.36% | 0.73% | -2.49% | -2.01% | |
| Return on Capital Employed (ROCE) | -6.90% | -2.50% | 0.70% | 1.10% | -3.80% | -3.00% | |
| Earnings Yield | -23.86% | -23.39% | -24.92% | -3.44% | 0.80% | -3.73% | |
| FCF Yield | 0.47% | -0.97% | -2.17% | -0.71% | 0.63% | 1.78% | |
| Buyback Yield / Dilution | 2.20% | -0.44% | -0.65% | 0.50% | -2.90% | 1.06% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.